Abstract:Objective This meta-analysis attempted to derive pooled estimates for the associations between various cardiovascular-renal disorders and the deletion/insertion (D/I) polymorphism of the angiotensin converting enzyme (ACE) gene.Methods Case-control studies were combined, using the Mantel-Haenszel approach. Joint P values for continuous variables were calculated by Stouffer's method. Continuous measurements reported in different units were expressed on a percentage scale using the within-study mean of the II genotype as the denominator.Results The computerized database used for this analysis included 145 reports with an overall sample size of 49 959 subjects. Overall, possession of the D allele was associated with an increased risk of atherosclerotic and renal microvascular complications. In comparison with the II reference group, the excess risk in DD homozygotes (P < 0.001) was 32% for coronary heart disease (CHD; 30 studies), 45% for myocardial infarction (20 studies), 94% for stroke (five studies) and 56% for diabetic nephropathy (11 studies). The corresponding risk in DI heterozygotes amounted to 11% (P = 0.02), 13% (P = 0.02), 22% (P = 0.10) and 40% (P < 0.001), respectively. Hypertension (23 studies), left ventricular hypertrophy (five studies), hypertrophic or dilated cardiomyopathy (eight studies) and diabetic retinopathy (two studies) were not related to the DI polymorphism. Publication bias was observed for CHD, myocardial infarction and microvascular nephropathy, but not hypertension. In studies with DNA amplification in the presence of insertion-specific primers, the risk associated with the DD genotype increased to 150% [95% confidence interval (CI) 76-256; four studies] for diabetic nephropathy, but decreased to 12% (95% CI -3 to 28; seven studies) for CHD and 14% (95% CI -6 to 37; four studies) for myocardial infarction. On the other hand, the pooled odds ratios did not materially change if the metaanalysis was limited to articles published in journals with an impact factor of at least 4. Furthermore, compared with the II control group, the circulating ACE levels (29 studies) were raised 58 and 31% (P < 0.001) in DD and DI subjects, respectively. In contrast, plasma renin (10 studies), systolic and diastolic blood pressure (46 studies) and body mass index (30 studies) were not associated with the D allele.Conclusion The D allele is not associated with hypertension, but behaves as a marker of atherosclerotic cardiovascular complications and diabetic nephropathy. These associations do not necessarily imply a causal relationship and may have been inflated by publication bias. Nevertheless, their possible therapeutic implications may be subject to further investigation in prospective (intervention) studies. (C) Rapid Science Publishers ISSN 0263-6352.

ASSOCIATION BETWEEN AN INSERTION/DELETION POLYMORPHISM OF ANGIOTENSIN I CONVERTING ENZYME GENE AND CHINESE TYPE 2 DIABETES WITH RETINOPATHY

Association Between Angiotensin-Converting Enzyme Gene Polymorphism and Diabetic Retinopathy in the Chinese Population

Association of the Genetic Polymorphism of Angiotensin-Converting Enzyme and Idiopathic Dilated Cardiomyopathy

Angiotensin Converting Enzyme Gene Polymorphism Andtype 2 Diabetic Retinopathy

Association Between Angiotensin Ⅰ Converting Enzyme Gene Insertion/deletion Polymorphism and Type 2 Diabetes Nephropathy

Association Between Polymorphism of C936T in Vascular Endothelial Growth Factor Gene and Type 2 Diabetic Nephropathy

Association Between the Polymorphism of Urotensin II Gene and the Onset of Diabetic Nephropathy in Chinese Subjects

Polymorphism of Angiotensin-Converting Enzyme Gene and Type 2 Diabetes

Association of Angiotensin Converting Enzyme Gene Polymorphism with Type 2 Diabetes Mellitus

Association of Angiotensin I Converting Enzyme, Angiotensin II Type 1 Receptor and Angiotensin I Converting Enzyme 2 Gene Polymorphisms with the Dyslipidemia in Type 2 Diabetic Patients of Chinese Han Origin

Association of C（-106）T Polymorphism in Aldose Reductase Gene with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes Mellitus

Insertion/Deletion Polymorphism of the ACE Gene is Associated with Type 2 Diabetes

Association of vascular endothelial growth factor -634C/G polymorphism and diabetic retinopathy in type 2 diabetic Han Chinese.

Insertion/deletion Polymorphism of the Angiotensin I—converting Enzyme Gene in Patients with Hypertension, Non—insulin-Dependent Diabetes Mellitus, and Coronary Heart Disease in Taiwan

Association Study of Angiotensin Converting Enzyme Polymorphism with Myocardial Infarction in Chinese

ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM IN UNTREATED ESSENTIAL HYPERTENSION AND RESPONSE TO ANGIOTENSIN CONVERTING ENZYME INHIBITORS

Polymorphisms in the Vascular Endothelial Growth Factor Gene and the Risk of Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes

A Dinucleotide Repeat Polymorphism of Matrix Metalloproteinase-9 Gene is Associated with Type 2 Diabetic Retinopathy

The Deletion/insertion Polymorphism of the Angiotensin Converting Enzyme Gene and Cardiovascular-Renal Risk.

The Angiotensin-I Converting Enzyme Gene I/D Variation Contributes to End-Stage Renal Disease Risk in Chinese Patients with Type 2 Diabetes Receiving Hemodialysis.

Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis.